08/09/2024
6:01 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
4:06 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:07 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:09 PM | Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:11 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/31/2024
5:27 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
5:28 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:16 AM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
05/29/2024
6:33 AM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
6:34 AM | Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:46 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
6:47 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:05 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
3:34 PM | Zentalis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024
3:36 PM | Zentalis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/11/2024
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:02 AM | Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:30 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:14 PM | Zentalis Pharmaceuticals (Filer)
| Form S-3ASR | |
02/29/2024
4:20 PM | Zentalis Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
6:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:08 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:43 PM | Avidity Partners Management LP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
7:21 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:22 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
7:23 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
7:25 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:40 AM | WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/05/2024
6:11 PM | Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:12 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:13 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:14 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:15 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:16 PM | HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
8:26 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here. |
02/02/2024
8:27 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:28 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:29 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
8:26 PM | Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:52 AM | STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/25/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:03 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:19 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2024
7:21 PM | Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
4:47 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:24 PM | Blackwell Kimberly (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:24 PM | Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
8:04 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
8:06 AM | Zentalis Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
2:40 PM | EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
| Form SC 13G | |
10/06/2023
6:18 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
6:19 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
6:19 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
4:00 PM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
7:25 PM | Epperly Melissa B, (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2023
7:26 PM | Bunker Kevin D. (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2023
7:28 PM | Brownstein Carrie (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:11 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
6:00 AM | Zentalis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
3:09 PM | Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free ZNTL Stock Alerts